The Pharmacokinetics and Safety of Single-dose and Parallel Comparisons in Patients With NSCLC Treated With JS001
Clinical trial NCT03301688 · COMPLETED
Trial details
- NCT number
- NCT03301688
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2018-09-15
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.